BioLife Solutions, Inc. (FRA:BJX1)
Germany · Delayed Price · Currency is EUR 22.80
0.00 (0.00%)
Last updated: Dec 1, 2025, 12:13 PM CET
BioLife Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 100.14 | 82.25 | 75.86 | 76.24 | 119.16 | 48.09 | Upgrade | |
Revenue Growth (YoY) | 87.53% | 8.44% | -0.50% | -36.02% | 147.79% | 75.69% | Upgrade |
Cost of Revenue | 35.77 | 28.58 | 29.92 | 29.33 | 80.98 | 20.24 | Upgrade |
Gross Profit | 64.37 | 53.67 | 45.93 | 46.91 | 38.18 | 27.85 | Upgrade |
Selling, General & Admin | 56.57 | 50.15 | 55.97 | 44.93 | 47.67 | 21.69 | Upgrade |
Research & Development | 9.55 | 7.91 | 12.07 | 8.67 | 11.82 | 6.72 | Upgrade |
Amortization of Goodwill & Intangibles | 2.79 | 2.74 | 3.52 | 3.99 | 8.2 | 3.03 | Upgrade |
Operating Expenses | 68.91 | 60.8 | 71.57 | 57.59 | 67.7 | 31.44 | Upgrade |
Operating Income | -4.54 | -7.13 | -25.63 | -10.68 | -29.52 | -3.59 | Upgrade |
Interest Expense | -0.02 | -0.72 | -1.45 | -0.28 | -0.49 | - | Upgrade |
Interest & Investment Income | 1.87 | - | - | - | - | 0.04 | Upgrade |
Other Non Operating Income (Expenses) | 0.63 | 0.5 | 1.3 | 0.66 | 0.17 | 3.6 | Upgrade |
EBT Excluding Unusual Items | -2.06 | -7.35 | -25.78 | -10.3 | -29.84 | 0.05 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -2.77 | -1.08 | Upgrade |
Gain (Loss) on Sale of Investments | - | -4.07 | - | 0.7 | - | 1.32 | Upgrade |
Other Unusual Items | - | - | 7.31 | 4.75 | 3.58 | -1.58 | Upgrade |
Pretax Income | -17.58 | -11.43 | -18.47 | -4.85 | -29.03 | -1.28 | Upgrade |
Income Tax Expense | 0.25 | -0.04 | -0.02 | -5.24 | -20.12 | -3.26 | Upgrade |
Earnings From Continuing Operations | -17.82 | -11.39 | -18.45 | 0.39 | -8.91 | 1.98 | Upgrade |
Earnings From Discontinued Operations | 14.62 | -8.8 | -49.56 | -140.19 | - | - | Upgrade |
Net Income to Company | -3.21 | -20.18 | -68 | -139.81 | -8.91 | 1.98 | Upgrade |
Net Income | -3.21 | -20.18 | -68 | -139.81 | -8.91 | 1.98 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.16 | Upgrade |
Net Income to Common | -3.21 | -20.18 | -68 | -139.81 | -8.91 | 1.82 | Upgrade |
Shares Outstanding (Basic) | 47 | 46 | 44 | 42 | 39 | 27 | Upgrade |
Shares Outstanding (Diluted) | 47 | 46 | 44 | 43 | 39 | 27 | Upgrade |
Shares Change (YoY) | 3.88% | 5.37% | 1.50% | 11.87% | 41.01% | 40.32% | Upgrade |
EPS (Basic) | -0.07 | -0.44 | -1.56 | -3.29 | -0.23 | 0.07 | Upgrade |
EPS (Diluted) | -0.07 | -0.44 | -1.56 | -3.29 | -0.23 | -0.06 | Upgrade |
Free Cash Flow | 10.04 | 3.14 | -23.74 | -22.41 | -19.35 | -1.16 | Upgrade |
Free Cash Flow Per Share | 0.21 | 0.07 | -0.54 | -0.52 | -0.50 | -0.04 | Upgrade |
Gross Margin | 64.28% | 65.25% | 60.55% | 61.53% | 32.04% | 57.92% | Upgrade |
Operating Margin | -4.53% | -8.67% | -33.79% | -14.01% | -24.77% | -7.46% | Upgrade |
Profit Margin | -3.20% | -24.54% | -89.65% | -183.38% | -7.48% | 3.79% | Upgrade |
Free Cash Flow Margin | 10.02% | 3.81% | -31.29% | -29.39% | -16.24% | -2.42% | Upgrade |
EBITDA | -1.9 | -1.64 | -18.5 | -3.1 | -16.65 | 1.48 | Upgrade |
EBITDA Margin | -1.90% | -1.99% | -24.39% | -4.06% | -13.98% | 3.08% | Upgrade |
D&A For EBITDA | 2.64 | 5.49 | 7.13 | 7.58 | 12.87 | 5.07 | Upgrade |
EBIT | -4.54 | -7.13 | -25.63 | -10.68 | -29.52 | -3.59 | Upgrade |
EBIT Margin | -4.53% | -8.67% | -33.79% | -14.01% | -24.77% | -7.46% | Upgrade |
Revenue as Reported | 100.14 | 82.25 | 75.86 | 76.24 | 119.16 | 48.09 | Upgrade |
Advertising Expenses | - | 0.9 | 0.8 | 0.4 | 0.6 | 0.17 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.